Tower has confirmed the sale of its investments business to Fisher Funds for $79 million.
The managing director of Tower, Rob Flannagan, says all conditions of the sale have now been satisfied.
Tower will return $120 million to shareholders on 12 April, following the sale of its health business late last year, but it's yet to decide what to do with the money from the sale of its investment arm.
